Maturing in one year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Interest and other income Interest And Other Income Loss Interest And Other Income Loss Term B And C Loan Term B And C Loan [Member] Term B And C Loan Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Foreign Current Foreign Tax Expense (Benefit) Total lease payments Lessee, Operating Lease, Liability, to be Paid Long-term debt, gross Long-Term Debt, Gross Non-cash interest expense on royalty financing obligations and secured term loan and amortization of debt issuance costs Noncash Interest Expense And Amortization Of Debt Issuance Costs Noncash Interest Expense And Amortization Of Debt Issuance Costs Entity Address, Postal Zip Code Entity Address, Postal Zip Code Property, Plant and Equipment [Abstract] Deferred expense (benefit) provision: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Income Tax Disclosure [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Incentive Plan Incentive Plan [Member] Incentive Plan MidCap Financial Services, LLC MidCap Financial Services LLC [Member] MidCap Financial Services LLC Total property and equipment Property, Plant and Equipment, Gross Receivable [Domain] Receivable [Domain] Income Tax Disclosure [Abstract] Collaborative and other research and development Collaborative And Other Research And Development [Member] Collaborative And Other Research And Development (Gain) loss on extinguishment of debt Increase Decrease In Extinguishment Of Debt Increase Decrease In Extinguishment Of Debt Fixed assets Deferred Tax Liabilities, Property, Plant and Equipment Foreign Exchange Contract Foreign Exchange Contract [Member] Additional paid-in capital Additional Paid in Capital Proceeds from issuance or sale of equity, total Proceeds from Issuance or Sale of Equity Inventory adjustments Inventory Adjustments Derivative, gain on derivative Derivative, Gain on Derivative Financial Instruments [Domain] Financial Instruments [Domain] UAB UAB [Member] UAB Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Statistical Measurement [Domain] Statistical Measurement [Domain] Number of Stock Option Awards Exercisable and their Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] Proceeds from issuance of debt Proceeds from Issuance of Debt Exercise of stock options, net (in shares) Options outstanding, stock option awards exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Net deferred tax assets (liabilities) Deferred Tax Assets, Net Debt instrument, LIBOR cap Debt Instrument Libor Cap Debt Instrument Libor Cap Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Exercise Price Range 04 Exercise Price Range 04 [Member] Exercise Price Range 04 Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Share-Based Payment Arrangement [Abstract] Annual Net Sales Over $550,000 Annual Net Sales Over 550000 [Member] Annual Net Sales Over 550000 Domestic Tax Authority Domestic Tax Authority [Member] Secured Credit Facility, Third Tranche Secured Credit Facility Third Tranche [Member] Secured Credit Facility Third Tranche Athyrium Athyrium [Member] Athyrium Net loss Net loss Net Income (Loss) Attributable to Parent Income Tax Disclosure [Line Items] Income Tax Disclosure [Line Items] Income Tax Disclosure Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Antidilutive securities excluded from computation of earnings per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Royalty purchase agreement, royalties, percentage of purchase price Royalty Purchase Agreement Royalties Percentage Of Purchase Price Royalty Purchase Agreement Royalties Percentage Of Purchase Price RAPIVAB RAPIVAB [Member] RAPIVAB Secured debt, total Secured Debt Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] Equity Component [Domain] Equity Component [Domain] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount JPR Royalty Sub LLC JPR Royalty Sub LLC [Member] JPR Royalty Sub LLC Other collaborations Other Collaborations [Member] Other Collaborations Term Loan A and B Drawn Term Loan A And B Drawn [Member] Term Loan A And B Drawn Exercise price range, shares outstanding (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Additions to current period tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Award vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Lease, Obligations Lessee, Operating Leases [Text Block] Weighted average exercise price (in dollars per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Deferred financing costs Payments of Financing Costs Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Billed Billed Revenues [Member] Plan Name [Axis] Plan Name [Axis] Estimated Fair Value Estimated Fair Value Debt Securities, Available-for-Sale Hedging Designation [Domain] Hedging Designation [Domain] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Change in fair value of foreign currency derivative Increase (Decrease) in Derivative Assets Derivative Instrument [Axis] Derivative Instrument [Axis] Plan Name [Domain] Plan Name [Domain] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Exercise Price Range 06 Exercise Price Range 06 [Member] Exercise Price Range 06 Shares issued, price per share (in dollars per share) Shares Issued, Price Per Share Derivative, loss on derivative Derivative, Loss on Derivative Award Type [Axis] Award Type [Axis] Royalty purchase agreement, royalties, purchase price, amount Royalty Purchase Agreement Royalties Purchase Price Amount Royalty Purchase Agreement Royalties Purchase Price Amount PIK Interest Payment is Made Pik Interest Payment Is Made [Member] Pik Interest Payment Is Made Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Lease financing obligation Operating Lease, Liability, Current Potential milestone payments receivable if regulatory approval before december 31, 2021 Potential Milestone Payments Receivable If Regulatory Approval Before December 31, 2021 Potential Milestone Payments Receivable If Regulatory Approval Before December 31, 2021 Debt instrument, LIBOR floor Debt Instrument Libor Floor Debt Instrument Libor Floor Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Significant Accounting Policies and Concentrations of Risk [Table] Significant Accounting Policies and Concentrations of Risk [Table] Significant Accounting Policies and Concentrations of Risk Fair Value of the Company's Investments by Type Debt Securities, Available-for-Sale [Table Text Block] Peramivir PERAMIVIR [Member] PERAMIVIR Expenses Costs and Expenses [Abstract] Lender Name [Axis] Lender Name [Axis] Stock option awards forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Receivables [Abstract] Other Commitments [Domain] Other Commitments [Domain] Document Annual Report Document Annual Report Transaction costs TransactionCosts TransactionCosts Legal Entity [Axis] Legal Entity [Axis] Secured term loan Long-Term Debt, Excluding Current Maturities Secured Credit Facility, Second Tranche Secured Credit Facility Second Tranche [Member] Secured Credit Facility Second Tranche Certificates of deposit Certificates of Deposit [Member] Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Royalty purchase agreement, royalties, percentage of annual net sales, based on reduction in sales Royalty Purchase Agreement Royalties Percentage Of Annual Net Sales Based On Reduction In Sales Royalty Purchase Agreement Royalties Percentage Of Annual Net Sales Based On Reduction In Sales Royalty purchase agreement, royalties, percentage of global annual net sales Royalty Purchase Agreement Royalties Percentage Of Global Annual Net Sales Royalty Purchase Agreement Royalties Percentage Of Global Annual Net Sales Issuance of common stock, net Stock Issued During Period, Value, New Issues Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Laboratory equipment Laboratory Equipment [Member] Laboratory Equipment Summary of Property and Equipment Property, Plant and Equipment [Table Text Block] Investments Debt Securities, Available-for-Sale, Current Current expense provision: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Document Type Document Type Property, plant and equipment, useful life (in years) Property, Plant and Equipment, Useful Life Options outstanding, stock option awards cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Debt Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Annual Net Sales Between $150,000 and $230,000 Annual Net Sales Between 150000 And 230000 [Member] Annual Net Sales Between 150000 And 230000 Entity Shell Company Entity Shell Company Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Exercise Price Range [Axis] Exercise Price Range [Axis] Collateral for Credit Collateral For Credit [Member] Collateral For Credit Compensation cost expected to be recognized next year Employee Service Shar-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Next Year Employee Service Shar-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Next Year 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Annual Net Sales Under $1.5 Million Annual Net Sales Under $1.5 Million [Member] Annual Net Sales Under $1.5 Million Financial Instrument [Axis] Financial Instrument [Axis] Debt instrument, exit fee, percentage of principal Debt Instrument Exit Fee Percentage Of Principal Debt Instrument Exit Fee Percentage Of Principal Warrants exercised (in shares) Class Of Warrant Or Right Exercised During Period Class Of Warrant Or Right Exercised During Period Compensation cost expected to be recognized year two Employee Service Share-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two Employee Service Share-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two Document Period End Date Document Period End Date Share-Based Payment Arrangement, Tranche One Share-Based Payment Arrangement, Tranche One [Member] The Company Description Of Company [Policy Text Block] Description Of Company Term B Loan Term B Loan [Member] Term B Loan Trade Receivables Trade Receivables [Text Block] Trade Receivables Right of use asset Deferred Tax Liabilities Right-Of-Use Assets Deferred Tax Liabilities Right-Of-Use Assets Total assets Assets Debt Disclosure [Abstract] Schedule of the Maturity of Investments Debt Securities, Held-to-Maturity [Table Text Block] Litigation settlement, amount awarded from other party Litigation Settlement, Amount Awarded from Other Party Income Statement Location [Axis] Income Statement Location [Axis] Performance Shares Performance Shares [Member] Revenue-related reserves for discounts and allowances Revenue-Related Reserves For Discounts And Allowances Revenue-Related Reserves For Discounts And Allowances Trade Accounts Receivable Trade Accounts Receivable [Member] Accrued expenses Total accrued expenses Accrued Liabilities, Current Weighted average exercise price, stock option awards exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Long-term investments Long-Term Investments Interest expense, debt, total Interest Expense, Debt Compensation and benefits Employee-related Liabilities, Current Other Commitments [Axis] Other Commitments [Axis] Amortization of debt financing costs and original issue discounts Amortization Of Debt Financing Costs And Original Issue Discounts Amortization Of Debt Financing Costs And Original Issue Discounts Renewable period of agreement (year) Renewable Period Of Agreement Renewable Period Of Agreement Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders’ deficit: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Performance-based Restricted Stock Units Performance-based Restricted Stock Units [Member] Represents performance-based restricted stock units. Foreign currency losses, net Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Milestone revenue Milestone [Member] Milestone Awards available, stock option awards cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Canceled in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Canceled in Period Weighted Average Assumptions for Stock Option Awards Granted to Employees and Directors Under the Plans Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Schedule of Components of Income Tax (Benefit) Expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Options, vested in period, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Award Type [Domain] Award Type [Domain] Audit Information [Abstract] Audit Information Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Gain (loss) on extinguishment of debt Gain (Loss) on Extinguishment of Debt Options, exercisable, weighted average remaining contractual term (year) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Trade Receivables Receivable [Policy Text Block] Computer Equipment Computer Equipment [Member] Finished goods Inventory, Finished Goods, Gross Derivative Contract [Domain] Derivative Contract [Domain] Deferred tax liabilities: Deferred Tax Liabilities, Deferred Expense [Abstract] Total revenues Revenue from Contract with Customer, Including Assessed Tax Entity Registrant Name Entity Registrant Name Issuance of common stock, net (in shares) Stock Issued During Period, Shares, New Issues CSL Limited CSL Limited [Member] CSL Limited 2021 RPI Royalty Agreement Twenty Twenty One RPI Royalty Agreement [Member] Twenty Twenty One RPI Royalty Agreement Debt instrument, prepayment fee, percentage of accrued interest Debt Instrument Prepayment Fee Percentage Of Accrued Interest Debt Instrument Prepayment Fee Percentage Of Accrued Interest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price [Abstract] Maximum number of products, doses Maximum Number Of Products Permitted To Be Obtained, Doses Maximum Number Of Products Permitted To Be Obtained, Doses Expected Dividend Yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Software Software Development [Member] Exercise price range, upper range limit (in usd per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Entity Address, City or Town Entity Address, City or Town Base Contract Base Contract [Member] Base Contract Royalty revenues paid and payable Royalties Revenues Paid And Payable Royalties Revenues Paid And Payable Employee 401(k) Plan Retirement Benefits [Text Block] Leases [Abstract] Annual Net Sales Over $3 Billions Annual Net Sales Over 3 Billions [Member] Annual Net Sales Over 3 Billions Debt instrument, covenant, minimum unrestricted cash and cash equivalents Debt Instrument Covenant Minimum Unrestricted Cash And Cash Equivalents Debt Instrument Covenant Minimum Unrestricted Cash And Cash Equivalents Annual Net Sales Between $350,000 and $550,000 Annual Net Sales Between 350000 And 550000 [Member] Annual Net Sales Between 350000 And 550000 Milestone payment minimum Milestone Payment Minimum Milestone Payment Minimum Minimum Minimum [Member] Restricted cash Restricted Cash and Cash Equivalents, Current Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Royalty revenue Royalty [Member] Common stock, par or stated value(in usd per share) Common Stock, Par or Stated Value Per Share Net proceeds from secured term loan Proceeds from Issuance of Secured Debt Inventory obsolescence expense Inventory Write-down After Fourth Anniversary After Fourth Anniversary [Member] After Fourth Anniversary Interest reserve InterestReserve InterestReserve Debt issuance costs, net, total Debt Issuance Costs, Net Auditor Name Auditor Name Torii Pharmaceutical Co., Ltd. Torii Pharmaceutical Co [Member] Torii Pharmaceutical Co Operating loss carryforwards, total Operating Loss Carryforwards Trading Symbol Trading Symbol Entity File Number Entity File Number Weighted Average Remaining Life Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Research and development Research and Development Expense Annual Net Sales Under $350,000 Annual Net Sales Under 350000 [Member] Annual Net Sales Under 350000 Deferred revenue Deferred Revenue, Current Schedule of Royalty Financing Obligations RoyaltyFinancingObligationsTableTextBlock [Table Text Block] RoyaltyFinancingObligationsTableTextBlock Percentage of common stock shares, ending Percentage Of Common Stock Shares Ending Percentage Of Common Stock Shares Ending Title of Individual [Axis] Title of Individual [Axis] Royalty purchase agreement, royalties, percentage of annual net sales RoyaltyPurchaseAgreementRoyaltiesPercentageOfAnnualNetSales RoyaltyPurchaseAgreementRoyaltiesPercentageOfAnnualNetSales Marketable Securities [Line Items] Marketable Securities [Line Items] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Awards available, Restricted stock awards granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Expiration of attribute carryforwards Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards Proceeds from additional credit facility Proceeds from Lines of Credit Research and development tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Number of stock option awards vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Thirty-six Equal Monthly Installments Thirty-six Equal Monthly Installments [Member] Information on the vesting period. Raw materials Inventory, Raw Materials, Gross Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Awards available, stock option awards cancelled (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award Options Forfeitures In Period Awards Available Share-Based Compensation Arrangement By Share-Based Payment Award Options Forfeitures In Period Awards Available Development costs Accrued Development Costs Accrued Development Costs Royalties Monetiztions [Table] Royalties Monetiztions [Table] Royalties Monetiztions Awards available number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Arbitration Proceedings of SUL Agreement Arbitration Proceedings Of Sul Agreement [Member] Arbitration Proceedings Of Sul Agreement Investments Investments and Other Noncurrent Assets [Text Block] Income Taxes Income Tax Disclosure [Text Block] Non-employee Directors Non Employee Directors [Member] Non Employee Directors Payment for debt extinguishment or debt prepayment cost Payment for Debt Extinguishment or Debt Prepayment Cost Issued performance-based RSU award (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Thirty-six Equal Monthly Installments Thirty six Equal Monthly Installments [Member] Thirty six Equal Monthly Installments Credit Facility [Domain] Credit Facility [Domain] Class of warrant or right, warrants issued, price per warrant (in dollars per share) Class Of Warrant Or Right Warrants Issued Price Per Warrant Class Of Warrant Or Right Warrants Issued Price Per Warrant Royalty Royalty Expense Reversal Of Expense Royalty Expense Reversal Of Expense Class of warrant or right, exercise price of warrants or rights (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Earnings per share, basic (in usd per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three December 2019 December 2019 [Member] December 2019 Reclassification from accumulated other comprehensive income, current period, before tax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Inventory Inventory, Policy [Policy Text Block] Trade Receivables [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ deficit Beginning balance Ending balance Stockholders' Equity Attributable to Parent Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at end of year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Tax credit carryforward, amount Tax Credit Carryforward, Amount Vesting [Domain] Vesting [Domain] Other Deferred Tax Assets, Other Entity Interactive Data Current Entity Interactive Data Current Interest Expense and Royalty Financing Obligations Interest Expense And Deferred Financing Costs Policy [Policy Text Block] Interest Expense And Deferred Financing Costs Policy Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Award Date [Domain] Award Date [Domain] Accrued Interest Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Accumulated Deficit Retained Earnings [Member] Leasing obligations Deferred Tax Assets Leasing Obligations Deferred Tax Assets Leasing Obligations Royalty income Deferred Tax Assets Royalty Income Deferred Tax Assets Royalty Income Gain (loss) related to litigation settlement, total Gain (Loss) Related to Litigation Settlement Common Stock Common Stock [Member] Stock-Based Compensation Allocation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Receivable Type [Axis] Receivable Type [Axis] Lease, Cost Lease, Cost [Table Text Block] Number of shares available for grant (in shares) Awards available, beginning balance (in shares) Awards available, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Income Tax Income Tax, Policy [Policy Text Block] Revenue Recognition Revenue [Policy Text Block] Statement [Table] Statement [Table] Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Receivables Receivables, Net, Current Furniture and fixtures Furniture and Fixtures [Member] Operating Lease, Liability [Abstract] Operating Lease, Liability [Abstract] Lease financing obligation Operating Lease, Liability, Noncurrent Research and development credits Deferred Tax Assets, Tax Credit Carryforwards, Research National Institute of Allergy and Infectious Diseases National Institute Of Allergy And Infectious Diseases [Member] National Institute Of Allergy And Infectious Diseases Statistical Measurement [Axis] Statistical Measurement [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Leasehold improvements Leasehold Improvements [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Trade receivables Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Litigation Case [Domain] Litigation Case [Domain] Green Cross Corporation Green Cross Corporation [Member] Green Cross Corporation Weighted average exercise price, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Debt instrument, commitment fee percentage Debt Instrument Commitment Fee Percentage Debt Instrument Commitment Fee Percentage Accumulated Other Comprehensive Income Comprehensive Income, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Capitalized R&D Deferred Tax Assets, in Process Research and Development Royalty rate if maintains sakigake designation RoyaltyRateIfMaintainsSakigakeDesignation RoyaltyRateIfMaintainsSakigakeDesignation Between the Third and Fourth Anniversaries Between The Third And Fourth Anniversaries [Member] Between The Third And Fourth Anniversaries Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative Selling, General and Administrative Expense Weighted average purchase price of shares purchased (in dollars per share) Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased Total current expense provision Current Income Tax Expense (Benefit) Operating lease assets, net Operating Lease, Right-of-Use Asset Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Product sales, net Product [Member] Accumulated Other Comprehensive (Loss) Income AOCI Attributable to Parent [Member] Auditor Firm ID Auditor Firm ID Weighted average exercise price of stock option awards vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Aggregate lease expense Operating Lease, Expense Acquisition of property and equipment Payments to Acquire Productive Assets Document Transition Report Document Transition Report Foreign Tax Authority Foreign Tax Authority [Member] Local Phone Number Local Phone Number Inducement Plan Inducement Plan [Member] Inducement Plan Changes in the Number and Weighted-Average Grant-Date Fair Value Share-Based Payment Arrangement, Option, Activity [Table Text Block] Loss from operations Operating Income (Loss) Stock Plan Activities Share-Based Payment Arrangement, Activity [Table Text Block] Inventory Increase (Decrease) in Inventories Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Net federal and state operating losses Deferred Tax Assets, Operating Loss Carryforwards, Domestic Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets State and Local Jurisdiction State and Local Jurisdiction [Member] Debt Instrument Libor Interest Rate Debt Instrument Libor Interest Rate Debt Instrument Libor Interest Rate Common stock, shares, outstanding (in shares) Common Stock, Shares, Outstanding Total inventory Inventory, Gross Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Accumulated amortization Operating Lease Right-of-use Asset Accumulated Amortization Operating Lease Right-of-use Asset Accumulated Amortization Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax expense Income tax expense Income Tax Expense (Benefit) Valuation allowance Deferred Tax Assets, Valuation Allowance U.S. Federal and state Current Federal, State and Local, Tax Expense (Benefit) Equity Disclosure [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Awards available, stock option awards granted (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Awards Available Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Awards Available Preferred stock, par or stated value (in usd per share) Preferred Stock, Par or Stated Value Per Share 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] AECOM and IRL AECOM And IRL [Member] AECOM And IRL Options, grants in period, gross (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Public Float Entity Public Float Additional Paid-In Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Options, exercises in period, intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Cost of products sold Cost of Goods and Services Sold Term Loans Term Loans [Member] Term Loans Weighted average shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Expected Life Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Maximum number of shares per employee (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee Currency Hedge Agreement Currency Hedge Agreement Policy [Policy Text Block] Currency Hedge Agreement Policy Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Billing Status, Type [Axis] Billing Status, Type [Axis] Common stock, $0.01 par value; shares authorized — 450,000; Issued and outstanding – 187,906 and 184,350 at December 31, 2022 and 2021, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Maximum customary reduction on royalty rate MaximumCustomaryReductionOnRoyaltyRate MaximumCustomaryReductionOnRoyaltyRate Collaborative agreement contract value Collaborative Agreement Contract Value Collaborative Agreement Contract Value Restricted stock units, grants in period, weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Lessee, Operating Lease, Assets and Liabilities Lessee, Operating Lease, Assets and Liabilities [Table Text Block] Tabular disclosure of the assets and liabilities of the lessee's operating lease. Term A Loan Term A Loan [Member] Term A Loan Term Loans A, B and C Drawn and Cure Right Exercised Term Loans A B And C Drawn And Cure Right Exercised [Member] Term Loans A B And C Drawn And Cure Right Exercised Options, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Term C Loan Term C Loan [Member] Term C Loan Maturity period of short term investment (in months) Maturity Period Of Short Term Investment Maturity Period Of Short Term Investment Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Issuance of pre-funded warrants Adjustments to Additional Paid in Capital, Warrant Issued Proceeds from issuance of long-term Debt, total Proceeds from Issuance of Long-Term Debt Net proceeds from common stock issued under stock-based compensation plans Proceeds from Stock Options Exercised Other Income Other Income [Member] Common stock, shares, issued (in shares) Common Stock, Shares, Issued Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Stock option awards vested and expected to vest, weighted average remaining contractual life (year) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Potential aggregate maximum amount of funding CollaborativeAgreementContractCovenantMaximumAmountOfFunding CollaborativeAgreementContractCovenantMaximumAmountOfFunding Income Statement Location [Domain] Income Statement Location [Domain] Amendment Flag Amendment Flag Exercise Price Range 05 Exercise Price Range 05 [Member] Exercise Price Range 05 Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Debt instrument, face amount Debt Instrument, Face Amount The 2021 RPI Royalty Purchase Agreement The 2021 RPI Royalty Purchase Agreement [Member] The 2021 RPI Royalty Purchase Agreement Investments Investment, Policy [Policy Text Block] Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax OMERS Royalty Agreement OMERS Royalty Agreement [Member] OMERS Royalty Agreement Accrued Expenses Accrued Expenses Policy [Policy Text Block] Accrued Expenses Policy Employee stock purchase plan sales, net Stock Issued During Period, Value, Employee Stock Purchase Plan Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Litigation Case [Axis] Litigation Case [Axis] Significant Customers and Other Risks Concentration Of Market Risk Policy [Policy Text Block] Concentration Of Market Risk Policy Annual Net Sales Between $1.5 And $3 Million Annual Net Sales Between $1.5 And $3 Million [Member] Annual Net Sales Between $1.5 And $3 Million Annual Net Sales Range [Axis] Annual Net Sales Range [Axis] Annual Net Sales Range Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Private placement of senior secured notes PrivatePlacementOfSeniorSecuredNotes PrivatePlacementOfSeniorSecuredNotes Other assets Other Assets, Noncurrent Annual Net Sales Under $150,000 Annual Net Sales Under 150000 [Member] Annual Net Sales Under 150000 Depreciation and amortization Depreciation, Depletion and Amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Warrants Issued in Public Offering Warrants Issued In Public Offering [Member] Warrants Issued In Public Offering PhaRMA Notes PhaRMA Notes [Member] PhaRMA Notes Income tax benefit, federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Lessee, operating lease, term of contract (in years) Lessee, Operating Lease, Term of Contract U.S. Department of Health and Human Services US Department Of Health And Human Services [Member] US Department Of Health And Human Services Employee stock purchase plan sales, net (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Options outstanding, beginning balance (in shares) Options outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Debt instrument, unamortized discount (premium) and debt issuance costs, net, total Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Government contract receivable Government Contract Receivable U.S. Federal and state Deferred Federal, State and Local, Tax Expense (Benefit) Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effects of exchange rates on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Operating lease, payments Operating Lease, Payments Royalty purchase agreement, royalties, percentage of sublicense revenue in other markets Royalty Purchase Agreement Royalties Percentage Of Sublicense Revenue In Other Markets Royalty Purchase Agreement Royalties Percentage Of Sublicense Revenue In Other Markets Repayments of long-term debt, total Repayments of Long-Term Debt Compensation cost expected to be recognized year three Employee Service Share-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three Employee Service Share-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three Office equipment Office Equipment [Member] Share-based Payment Arrangement, Option Share-Based Payment Arrangement, Option [Member] Title of Individual [Domain] Title of Individual [Domain] Expected Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Exercise of stock options, net Stock Issued During Period, Value, Stock Options Exercised Long-term debt, total Long-Term Debt Open tax year Open Tax Year Common stock, shares authorized (in shares) Common Stock, Shares Authorized Debt instrument, minimum LIBOR Debt Instrument Minimum Libor Debt Instrument Minimum Libor ORLADEYO ORLADEYO [Member] ORLADEYO Maximum number of shares per employee, amount ShareBasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPerEmployeeAmount ShareBasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPerEmployeeAmount Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Non-cash Interest expense on Royalty financing obligation Non Cash Interest Expense On Royalty Financing Obligation Non Cash Interest Expense On Royalty Financing Obligation Maximum Maximum [Member] Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Amortization of premium/discount on investments Amortization Of Premium/Discount On Investments Amortization Of Premium/Discount On Investments Assets: Operating Lease Assets [Abstract] Operating Lease Assets Long-term investment maturity, minimum (in months) Longterm Investment Maturity Minimum Longterm Investment Maturity Minimum Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Royalty receivables from partners Royalty Receivables From Partners [Member] Royalty Receivables From Partners Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Work-in-process Inventory, Work in Process, Gross Deferred revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Incentive Plan and Inducement Plan Incentive Plan And Inducement Plan [Member] Incentive Plan And Inducement Plan Duties and taxes Taxes Payable, Current Royalty Monetization Royalty Monetization [Member] Royalty Monetization Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Weighted Average Grant-Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Maturity period of high quality marketable securities (in years) Maturity Period Of High Quality Marketable Securities Maturity Period Of High Quality Marketable Securities Senior Credit Facility Senior Credit Facility [Member] Senior Credit Facility Entity Small Business Entity Small Business Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Revenues Revenues [Abstract] Milestone payment maximum Milestone Payment Maximum Milestone Payment Maximum Purchases of investments Payments to Acquire Debt Securities, Available-for-Sale Cost of Product Sales Cost of Goods and Service [Policy Text Block] Significant Accounting Policies and Concentrations of Risk Significant Accounting Policies [Text Block] Total unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Options Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Paid-in-kind interest Paid-in-Kind Interest Receivable from awards for research and development contracts ExpectedReceivableFromAwardsForResearchAndDevelopmentContracts ExpectedReceivableFromAwardsForResearchAndDevelopmentContracts Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Title of 12(b) Security Title of 12(b) Security Notes payable, fair value disclosure Notes Payable, Fair Value Disclosure Schedule Of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Total operating expenses Costs and Expenses Non-Vested Stock Option Awards Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward] Options outstanding, stock awards granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Payment of senior credit facility Repayments of lines of credit Repayments of Lines of Credit Proceeds from awards for research and development contracts ProceedsFromAwardsForResearchAndDevelopmentContracts ProceedsFromAwardsForResearchAndDevelopmentContracts Deferred tax assets: Deferred Tax Assets, Tax Deferred Expense [Abstract] Debt Instrument [Line Items] Debt Instrument [Line Items] Interest payable Interest Payable Royalty financing obligations Balance Balance Future Royalties Payable Future Royalties Payable Annual license fee minimum Annual License Fee Minimum Annual License Fee Minimum Royalties Monetizations [Line Items] Royalties Monetizations [Line Items] Royalties Monetizations Total operating lease liabilities Total Operating Lease, Liability Obligations of U.S. Government and its agencies US Government Agencies Debt Securities [Member] Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Selling, general and administrative Selling, General and Administrative Expenses [Member] Net deferred tax assets (liabilities) Deferred Tax Liabilities, Net LIABILITIES AND STOCKHOLDERS’ DEFICIT Liabilities and Equity [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Royalty purchase agreement, royalties, percentage of annual net sales in other markets Royalty Purchase Agreement Royalties Percentage Of Annual Net Sales In Other Markets Royalty Purchase Agreement Royalties Percentage Of Annual Net Sales In Other Markets Weighted average exercise price, stock option awards granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, stock option awards cancelled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Inventory, net Total inventory, net Inventory, Net Accounts payable Accounts Payable, Current Income Tax Authority [Axis] Income Tax Authority [Axis] Milestone payment received Milestone Payment Received Milestone Payment Received Future Royalties Payable Future Royalties Payable [Member] Future Royalties Payable Hedging Designation [Axis] Hedging Designation [Axis] Auditor Location Auditor Location Write off of deferred debt issuance cost Write off of Deferred Debt Issuance Cost Net proceeds from royalty financing obligations Proceeds From Royalty Financing Obligation Proceeds From Royalty Financing Obligation Entity Filer Category Entity Filer Category Sale of common stock, net Proceeds from Issuance of Common Stock Weighted average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Total stock-based compensation expense Share-Based Payment Arrangement, Expense Royalty payments receivable, expiration term from first commercial (year) Royalty Payments Receivable Expiration Term From First Commercial Royalty Payments Receivable Expiration Term From First Commercial Security Exchange Name Security Exchange Name Weighted average exercise price, beginning balance (in dollars per share) Weighted average exercise price, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Royalties payable Royalties Payable Royalties Payable Accounts receivable, after allowance for credit loss, total Accounts Receivable, after Allowance for Credit Loss Preferred stock, $0.01 par value; shares authorized — 5,000; no shares outstanding Preferred Stock, Value, Issued Interest payable Increase (Decrease) in Interest Payable, Net Shares issued, price per share, closing price (in dollars per share) Shares Issued Price Per Share Closing Price Shares Issued Price Per Share Closing Price RPI 2021 and 2020 Intermediate Finance Trust RPI 2021 And 2020 Intermediate Finance Trust [Member] RPI 2021 And 2020 Intermediate Finance Trust Additional Development Options Additional Development Options [Member] Additional Development Options Annual Net Sales [Domain] Annual Net Sales [Domain] Annual Net Sales Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Revenue from contract with customer, excluding assessed tax Revenue from Contract with Customer, Excluding Assessed Tax Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer OMERS Capital Markets OMERS Capital Markets [Member] OMERS Capital Markets RPI 2019 Intermediate Finance Trust RPI 2019 Intermediate Finance Trust [Member] RPI 2019 Intermediate Finance Trust Cover [Abstract] Period of agreement (year) Period Of Agreement Period Of Agreement Long-Term Debt Type [Table] Schedule of Long-Term Debt Instruments [Table] Leases Lessee, Leases [Policy Text Block] Entity Voluntary Filers Entity Voluntary Filers Exercise price range, shares exercisable (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Number of product delivered, doses Number Of Product Delivered, Doses Number Of Product Delivered, Doses Contract term (year) ContractTerm ContractTerm Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Average maturity period of high quality marketable securities (in months) Average Maturity Period Of High Quality Marketable Securities Average Maturity Period Of High Quality Marketable Securities Other Supplemental Information Related to Leases Other Supplemental Information Related to Leases [Table Text Block] Other Supplemental Information Related to Leases Permanent items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Revenue Revenue from Contract with Customer [Text Block] Royalty purchase agreement, royalties, annual net sales payment threshold Royalty Purchase Agreement Royalties Annual Net Sales Payment Threshold Royalty Purchase Agreement Royalties Annual Net Sales Payment Threshold Shares issued, common stock, premium Shares Issued Common Stock Premium Shares Issued Common Stock Premium Annual Net Sales Over $230,000 Annual Net Sales Over 230000 [Member] Annual Net Sales Over 230000 Weighted average grant-date fair value (in dollars per share) Weighted average grant-date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Laboratory Equipment, Office Equipment and Software Laboratory Equipment Office Equipment And Software [Member] Laboratory Equipment Office Equipment And Software Risk-Free Interest Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Award Date [Axis] Award Date [Axis] Debt instrument, prepayment fee, percentage of principal voluntary payments Debt Instrument Prepayment Fee Percentage Of Principal Voluntary Payments Debt Instrument Prepayment Fee Percentage Of Principal Voluntary Payments Total liabilities and stockholders’ deficit Liabilities and Equity Number of additional products, doses Number Of Additional Products Doses Number Of Additional Products, Doses Debt instrument, term (month) Debt Instrument, Term Schedule Of Deferred Tax Assets And Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] 2020 RPI Royalty Agreement Twenty Twenty RPI Royalty Agreement [Member] Twenty Twenty RPI Royalty Agreement Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Amortization of debt issuance costs Amortization of Debt Issuance Costs Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Summary of Receivables ScheduleOfReceivablesFromCollaborationsTableTextBlock [Table Text Block] ScheduleOfReceivablesFromCollaborationsTableTextBlock Extinguishment of debt, amount Extinguishment of Debt, Amount Investments, All Other Investments [Abstract] Receivables Increase (Decrease) in Receivables Inventory Accrued Inventory Expense Accrued Inventory Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Total deferred tax assets Deferred Tax Assets, Gross Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Schedule Of Loss Before Provision For Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Provisions and accruals for interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Vesting [Axis] Vesting [Axis] Earnings per share, diluted (in usd per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Advance Royalties [Abstract] Award vesting period (year) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Royalty purchase agreement, royalties, percentage of annual net sales in key territories Royalty Purchase Agreement Royalties Percentage Of Annual Net Sales In Key Territories Royalty Purchase Agreement Royalties Percentage Of Annual Net Sales In Key Territories Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition ASPRBARDA Contract ASPRBARDA Contract [Member] ASPRBARDA Contract Exercise Price Range [Domain] Exercise Price Range [Domain] Total current liabilities Liabilities, Current Stock option awards vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Beginning balance Ending balance Unrecognized Tax Benefits Marketable Securities [Table] Marketable Securities [Table] Secured Credit Facility, First Tranche Secured Credit Facility First Tranche [Member] Secured Credit Facility First Tranche Receivables Billing Status [Domain] Receivables Billing Status [Domain] Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Expiration period (year) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Vest Upon Successful Completion of Specific Development Milestones Vest Upon Successful Completion Of Specific Development Milestones [Member] Vest Upon Successful Completion Of Specific Development Milestones Corporate debt securities Corporate Debt Securities [Member] Compensation cost expected to be recognized year four Employee Service Share-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four Employee Service Share-Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four Maturities of Operating Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Rate change Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Exercise price range, lower range limit (in usd per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Entity Address, Address Line One Entity Address, Address Line One Unbilled Unbilled Revenues [Member] Income Tax Authority [Domain] Income Tax Authority [Domain] Contract with customer, liability Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Royalty purchase agreement, royalties, maximum tiered profit share percentage on permitted sales in other markets Royalty Purchase Agreement Royalties Maximum Tiered Profit Share Percentage On Permitted Sales In Other Markets Royalty Purchase Agreement Royalties Maximum Tiered Profit Share Percentage On Permitted Sales In Other Markets Royalty Receivable Royalty Receivable [Member] Royalty Receivable Royalty Monetizations Royalty Monetization [Text Block] Royalty Monetization Exercise Price Range 03 Exercise Price Range 03 [Member] Exercise Price Range 03 Debt Covenant Terms [Domain] Debt Covenant Terms [Domain] Debt Covenant Terms Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Interest expense Interest Expense Percentage of salary to purchase common stock, maximum Percentage Of Salary To Purchase Common Stock Maximum Percentage Of Salary To Purchase Common Stock Maximum Weighted average grant-date fair value, option awards vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Credit Facility [Axis] Credit Facility [Axis] Unrealized loss on available for sale investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Sales and maturities of investments Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Reserves Inventory Valuation Reserves Inventory Inventory Disclosure [Text Block] Common Stock Purchase Agreement with RPI Common Stock Purchase Agreement With RPI [Member] Common Stock Purchase Agreement With RPI Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Matching contributions Defined Contribution Plan, Employer Discretionary Contribution Amount Equity [Abstract] Sale of pre-funded warrants Proceeds from Issuance of Warrants Inventory Disclosure [Abstract] Awards Available Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract] Interest Expense and Deferred Financing Costs Interest Expense And Royalty Financing Obligation Policy [Policy Text Block] Interest Expense And Royalty Financing Obligation Policy Entity Tax Identification Number Entity Tax Identification Number Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Shares issued, price per share, premium (in dollars per share) Shares Issued Price Per Share Premium Shares Issued Price Per Share Premium Accounts Payable and Accrued Liabilities [Abstract] Deferred debt fees and issuance costs Deferred Debt Fees And Issuance Costs Deferred Debt Fees And Issuance Costs Proceeds from license fees received Proceeds from License Fees Received Advertising expense Advertising Expense Significant Accounting Policies and Concentrations of Risk [Line Items] Significant Accounting Policies and Concentrations of Risk [Line Items] Significant Accounting Policies and Concentrations of Risk Summary of Revenues Disaggregation of Revenue [Table Text Block] Total deferred tax liabilities Deferred Tax Liabilities, Gross Revenue Recognition [Abstract] Term Loan A Drawn Term Loan A Drawn [Member] Term Loan A Drawn Summary Of The Differences Between The Company's Effective Tax Rate And Statutory Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] (Decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect State and local income taxes net of federal tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Term Loans A, B and C Drawn Term Loans A B And C Drawn [Member] Term Loans A B And C Drawn Debt Covenant Terms [Axis] Debt Covenant Terms [Axis] Debt Covenant Terms Entity Central Index Key Entity Central Index Key Maturing after one year through two years Maturing After One Year Through Two Years Maturing After One Year Through Two Years Exercise Price Range 01 Exercise Price Range 01 [Member] Exercise Price Range 01 Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Collaborative and Other Relationships Collaborative Arrangement Disclosure [Text Block] Other Collaborators Other Collaborators [Member] Other Collaborators Other Other Accrued Liabilities, Current Entity [Domain] Entity [Domain] City Area Code City Area Code Exercise price range, exercisable, weighted average exercise price (in dollars per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Vest 25% Each Year Until Fully Vested Vest 25 Percent Each Year Until Fully Vested [Member] Vest 25 Percent Each Year Until Fully Vested Professional fees Accrued Professional Fees, Current ASSETS Assets [Abstract] Legal fees Legal Fees Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Selling, General and Administrative Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] Retirement Benefits [Abstract] Non-vested stock option awards (in shares) Non-vested stock option awards (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Income tax benefit at federal statutory rate (21% for 2022, 2021 and 2020) Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Leases, Operating [Abstract] Options, grants in period, weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Variable Rate [Axis] Variable Rate [Axis] Exercise Price Range 02 Exercise Price Range 02 [Member] Exercise Price Range 02 August 2013 August 2013 [Member] August 2013 Prior to the Second Anniversary Prior To The Second Anniversary [Member] Prior To The Second Anniversary Research and development Research and Development Expense [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Percentage of common stock shares, beginning Percentage Of Common Stock Shares Beginning Percentage Of Common Stock Shares Beginning Proceeds from collaborators Proceeds from Collaborators BCX9930 BCX9930 [Member] BCX9930 Weighted average grant-date fair value, option awards forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Credit Agreement Credit Agreement [Member] Credit Agreement Income Tax Disclosure [Table] Income Tax Disclosure [Table] Income Tax Disclosure Warrants issued (in shares) Class Of Warrant Or Right Issued During Period Class Of Warrant Or Right Issued During Period Annual license fee maximum Annual License Fee Maximum Annual License Fee Maximum Between the Second and Third Anniversaries Between The Second And Third Anniversaries [Member] Between The Second And Third Anniversaries